Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 3
2006 1
2007 1
2008 3
2009 3
2010 4
2011 3
2012 6
2013 3
2014 2
2015 2
2016 3
2017 2
2018 1
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

37 results
Results by year
Filters applied: . Clear all
Page 1
Contrast agents: magnetic resonance.
Burtea C, Laurent S, Vander Elst L, Muller RN. Burtea C, et al. Handb Exp Pharmacol. 2008;(185 Pt 1):135-65. doi: 10.1007/978-3-540-72718-7_7. Handb Exp Pharmacol. 2008. PMID: 18626802 Review.
Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa.
Demine S, Balhuizen A, Debaille V, Joosten L, Fereau M, Chilla SNM, Millard I, Scharfmann R, Egrise D, Goldman S, Marchetti P, Gotthardt M, Laurent S, Burtea C, Eizirik DL. Demine S, et al. Among authors: Burtea C. Molecules. 2018 Aug 21;23(9):2100. doi: 10.3390/molecules23092100. Molecules. 2018. PMID: 30134599 Free PMC article.
Cell "vision": complementary factor of protein corona in nanotoxicology.
Mahmoudi M, Saeedi-Eslami SN, Shokrgozar MA, Azadmanesh K, Hassanlou M, Kalhor HR, Burtea C, Rothen-Rutishauser B, Laurent S, Sheibani S, Vali H. Mahmoudi M, et al. Among authors: Burtea C. Nanoscale. 2012 Sep 7;4(17):5461-8. doi: 10.1039/c2nr31185b. Epub 2012 Jul 30. Nanoscale. 2012. PMID: 22842341
Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier.
André S, Ansciaux E, Saidi E, Larbanoix L, Stanicki D, Nonclercq D, Vander Elst L, Laurent S, Muller RN, Burtea C. André S, et al. Among authors: Burtea C. J Alzheimers Dis. 2017;60(4):1547-1565. doi: 10.3233/JAD-170563. J Alzheimers Dis. 2017. PMID: 29036827
Significance of cell "observer" and protein source in nanobiosciences.
Laurent S, Burtea C, Thirifays C, Rezaee F, Mahmoudi M. Laurent S, et al. Among authors: Burtea C. J Colloid Interface Sci. 2013 Feb 15;392:431-445. doi: 10.1016/j.jcis.2012.10.005. Epub 2012 Oct 22. J Colloid Interface Sci. 2013. PMID: 23141702
Early detection of colonic dysplasia by magnetic resonance molecular imaging with a contrast agent raised against the colon cancer marker MUC5AC.
Rossez Y, Burtea C, Laurent S, Gosset P, Léonard R, Gonzalez W, Ballet S, Raynal I, Rousseaux O, Dugué T, Vander Elst L, Michalski JC, Muller RN, Robbe-Masselot C. Rossez Y, et al. Among authors: Burtea C. Contrast Media Mol Imaging. 2016 May;11(3):211-21. doi: 10.1002/cmmi.1682. Epub 2016 Jan 14. Contrast Media Mol Imaging. 2016. PMID: 26762591 Free article.
Toward a new and noninvasive diagnostic method of papillary thyroid cancer by using peptide vectorized contrast agents targeted to galectin-1.
Fanfone D, Despretz N, Stanicki D, Rubio-Magnieto J, Fossépré M, Surin M, Rorive S, Salmon I, Vander Elst L, Laurent S, Muller RN, Saussez S, Burtea C. Fanfone D, et al. Among authors: Burtea C. Med Oncol. 2017 Oct 6;34(11):184. doi: 10.1007/s12032-017-1042-y. Med Oncol. 2017. PMID: 28986753
37 results
Jump to page